KRISTINA WARREN: Open Payments
NPI 1437929007 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 25 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $158 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $146 |
| GlaxoSmithKline, LLC. | 4 | $93 |
| ABBVIE INC. | 3 | $68 |
| Lundbeck LLC | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $42 |
| Boston Scientific Corporation | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Exact Sciences Corporation | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
Products named: Wegovy, TRELEGY ELLIPTA, REXULTI, Kerendia, JOURNAVX, AIRSUPRA, VRAYLAR, DURYSTA.
Industry payments across AL — which companies pay providers there.
